NCT01366352View on ClinicalTrials.gov

Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Normal Volunteers
Interventions
DRUG

MNTX tablet (Formulation 1)

DRUG

MNTX tablet (Formulation 2)

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01366352 - Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets | Biotech Hunter | Biotech Hunter